Inspire Medical Systems (NYSE:INSP) logged another reimbursement win, this time with the nation’s largest private insurer, UnitedHealth. Minneapolis-based Inspire makes an eponymous device designed to treat obstructive sleep apnea using hypoglossal nerve stimulation. UnitedHealth has about 41 million lives under coverage, Inspire said. “We are very pleased to receive this positive coverage decision from UnitedHealthcare. […]
Respiratory
Vectura seeks another $44M in GSK patent win
Fresh off its $89.7 million jury award in a patent infringement case against GlaxoSmithKline (NYSE:GSK), British inhaler company Vectura has petitioned the court for an additional $44 million. On May 16, a jury in U.S. District Court for the District of Delaware awarded Vectura damages for the period from August 2016 through December 2018 for an infringement […]
Two deaths reported in recall of 6 million Teleflex endotracheal tubes
Teleflex (NYSE:TFX) is recalling multiple models of its Hudson RCI Sheridan and Sheridan endotracheal tubes due to complaints of the Sheridan connector disconnecting from the breathing circuit. Two deaths and one injury have been reported to the company, according to the FDA. Each of the more than 6 million recalled tracheal tubes includes an appropriately sized […]
ResMed study shows 170 million in Americas have sleep apnea
More than 170 million people in North and South America have sleep apnea, according to a new study released today by apnea device-maker ResMed (NYSE:RMD). The company reached the 170 million figure based on the American Academy of Sleep Medicine (AASM) 2012 criteria and termed it a “conservative” estimate. The figure represents 37% of adults […]
Windtree, Eleison tout feasibility study results
Windtree Therapeutics (OTCQB:WINT) and Eleison Pharmaceuticals have announced positive results of a feasibility study using Windtree’s aerosol delivery system (ADS) to deliver Eleison’s inhaled lipid cisplatin (ILC) for lung cancer. In the study, the ADS technology produced in 20 minutes approximately the same volume of aerosolized ILC that required approximately two hours to produce in a phase 2 […]
Report: Apple acquires pediatric asthma monitor dev Tueo Health
Apple (NSDQ:AAPL) has acquired pediatric asthma monitoring start-up Tueo Health, according to a recent CNBC report. Tueo Health was founded out of a Stanford-based incubator in 2015, according to a Stanford Byers Center for Biodesign posting, and was developing a mobile application intended to operate with commercial breathing sensors to monitor and help manage asthma symptoms […]
J&J’s Auris touts Monarch robotic bronchoscopy feasibility study
Johnson & Johnson‘s (NYSE:JNJ) Auris Health touted this week interim results from an independent feasibility study designed to assess the company’s Monarch robotic bronchoscopy technology. The Monarch Platform was cleared by the FDA in March 2018 for diagnostic and therapeutic bronchoscopic procedures. The study was set up to test the safety and feasibility of performing […]
Report: Google AI improves lung cancer diagnosis accuracy
Google (NSDQ:GOOG) has unveiled a new artificial intelligence system that outperformed six radiologists in detecting lung cancer, identifying 5% more cancers and cutting false positive rates by 11%, according to a STAT News report. The system was trained on 42,000 computed tomography scans taken in a National Institutes of Health clinical trial, according to the report. […]
Masimo touts hemoglobin monitoring study, wins FDA nod for Radius PPG
Masimo (NSDQ:MASI) recently touted results from a study of its SpHb monitoring tech exploring its ability to detect possible anemia in patients undergoing spine or cytoreductive surgery, and said it won FDA 510(k) clearance for its Radius PPG tetherless sensor. The Irvine, Calif.-based company said that results from its SpHb tech were published in the journal […]
Owlstone, Actelion ink collab pulmonary hypertension breath test dev deal
Owlstone Medical said today that it inked a strategic collaborative deal with Johnson & Johnson‘s (NYSE:JNJ) Actelion to discover and validate a breath-based test intended for the early diagnosis of pulmonary hypertension and its subtypes. Cambridge, UK-based Owlstone Medical said that the collaborative development program will be funded solely by Actelion, and that it will initially […]
J&J’s Auris touts prelim data from first-in-human study of Monarch platform
Johnson & Johnson‘s (NYSE:JNJ) subsidiary Auris Health today released preliminary results from a first-in-human feasibility study of its Monarch robotic interventional platform, which has FDA clearance for diagnostic and therapeutic bronchoscopic procedures. Preliminary data from the Benefit study of the Monarch platform was presented by Dr. Alexander Chen at the American Thoracic Society’s 2019 conference […]